Bristol Myers Squibb Company
430 E. 29th St
14th Floor
New York
New York
10016
United States
Tel: +1-800-332-2056
Website: http://www.bms.com/
About Bristol Myers Squibb Company
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.
At Bristol Myers Squibb, we believe in the power of science to address some of the most challenging diseases of our time. Our focus on these unmet needs comes during a remarkable time, when unprecedented scientific breakthroughs are advancing the treatment of disease as never before in human history.
We work every day to transform patients’ lives through science. Each day, our employees around the world work together for patients – they are at the center of everything we do. They inspire us. They are the reason we come to work each day.
We combine the agility of a biotech with the reach and resources of an established pharmaceutical company to create a global leading biopharma company powered by talented individuals who drive scientific innovation.
Possibility Lives at BMS!
2899 articles about Bristol Myers Squibb Company
-
Bristol-Myers Squibb Company Names Togo D. West, Jr. to Board of Directors
1/22/2008
-
Bristol-Myers Squibb Company to Announce Results for the Fourth Quarter and Full Year of 2007 on January 31
1/16/2008
-
Exelixis, Inc. Submits XL139 Diligence Report to Bristol-Myers Squibb
12/20/2007
-
European Commission Approves ATRIPLA(R), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
12/17/2007
-
Mixed Results from Bristol-Myers Squibb Company (Jobs) and Medarex, Inc. Melanoma Trials
12/11/2007
-
Bristol-Myers Squibb Company and Medarex, Inc. Top-Line Data Available from Three Ipilimumab Pivotal Trials in Patients with Advanced Metastatic Melanoma
12/11/2007
-
EDS Awarded $715 Million Contract for Bristol-Myers Squibb Company Information Services
12/10/2007
-
Bristol-Myers Squibb Company Outlines Strategy and Productivity Transformation Initiative During Update to Investment Community
12/5/2007
-
Bristol-Myers Squibb Company Names Alan J. Lacy to Board of Directors
12/4/2007
-
Bristol-Myers Squibb Company Begins Cutting Jobs
12/3/2007
-
Bristol-Myers Squibb Company, New Jersey Children's Hospital Launch Center for Immune System Disorders & Infectious Diseases Including HIV/AIDS
11/30/2007
-
Exelixis, Inc. to Receive Milestone Payment From Bristol-Myers Squibb for Achievement of Liver X Receptor Agonist Development Milestone
11/29/2007
-
Bristol-Myers Squibb Company to Webcast December 5 Business Update
11/28/2007
-
FDA Approves Bristol-Myers Squibb and Otsuka Pharmaceutical Co., Ltd.'s ABILIFY(R)
11/20/2007
-
Bristol-Myers Squibb Release: Powerful New Efficacy Data in Moderate and Severe Hypertensive Patients Supports FDA Approval of AVALIDE(R)
11/20/2007
-
The New England Journal of Medicine Study Shows Bristol-Myers Squibb and ImClone Systems Incorporated's ERBITUX(R) Improves Survival in Advanced Colorectal Cancer
11/15/2007
-
Otsuka Pharmaceutical Co., Ltd. and Bristol-Myers Squibb ABILIFY(R) (aripiprazole) Supplemental New Drug Application for the Treatment of Pediatric Patients with Bipolar I Disorder Accepted for Priority Review by the U.S. Food and Drug Administration
11/15/2007
-
National Comprehensive Cancer Network Receives Major Grant for Anti-Cancer Drug Study
11/15/2007
-
Bristol-Myers Squibb Post-Hoc Data Show Daily Activity Participation, Independence and Sleep Quality Improved in Adults with Moderate to Severe Rheumatoid Arthritis After Treatment with ORENCIA(R)
11/12/2007
-
Aureus Pharma Announces Renewal and Expansion of Licensing Agreement With Bristol-Myers Squibb for its AurSCOPE Knowledge Databases
11/12/2007